Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Advanced Portfolio Management for the Pharma and Biotech Industries

10 Jun 2013 - 12 Jun 2013 - Zurich, Switzerland

Bookmark and Share

In an era of declining R&D productivity and unprecedented loss of blockbuster patent exclusivity, the need to maximize the value of its core assets under ever constrained budgetary and human resources has never been more critical to the Pharmaceutical and Biotechnology industry. An integral part of strategic and business planning, the portfolio management process influences decisions that directly impact company fortunes — especially when advancing the right compounds under risk and uncertainty to create the potential for billions of dollars in long-term revenue.

Effective portfolio management requires foresight, discipline, preparation, and diligence, a serious challenge given the daily pressures faced by all organizations. Top-performing companies review, refresh, and execute their portfolio strategies on a continual basis through the application of excellent process, methodology, analysis, and decision making. For many organizations, however, numerous obstacles make it difficult to adopt a sustainably successful approach to portfolio management.

This Masterclass is your roadmap to maximizing portfolio value in accordance with management’s strategic and financial goals. Designed to improve companies’ abilities to progress compounds from the pre-clinical stage to commercial brand management, it showcases benchmarks and best practices for teams managing investments across the entire value chain – pre-clinical and clinical projects as well as marketed brand products.

The Masterclass will introduce the CREOPM™ Methodology, a unique, holistic framework for Portfolio Management developed by the trainer – Dr. Richard Bayney – President of Project & Portfolio Value Creation. Dr. Bayney, a 23-year veteran of the Pharmaceutical and Biotechnology industry, was Head of Strategic Planning at Bayer and Head of Portfolio Management & Decision Analysis at Bristol-Myers Squibb and Johnson & Johnson. CREOPM™ is an overarching Portfolio Management framework comprised of the following steps:

  • Categorize
  • Risk Analysis
  • Evaluate
  • Optimize
  • Prioritize
  • Manage


Reinforce your portfolio management strategy and enable execution with the CREOPM™ framework

Follow a step-by-step guide to improve strategic planning, create the criteria necessary to advance some projects while discontinuing others, and make the best use of constrained budgetary and human resources by maximizing strategic and financial value. Understand team members’ roles in portfolio analysis and how to influence executive decision-making irrespective of your hierarchical level within the organization.

Create nimble development strategies, boost revenues, and extend market exclusivity

Portfolio management of branded medicines stretches from discovery to patent expiration, so it is important to ensure that the transitions from drug discovery to clinical development, registration, and lifecycle management are relatively seamless through a carefully orchestrated ‘push-pull’ mechanism i.e. ‘push’ from discovery and ‘pull’ from commercial. Learn how to create investment options, enable efficient decision-making, analyze ROI, and continuously build equity by maximizing portfolio value under constrained budgetary and human resources.

Build portfolio management excellence

In a rapidly evolving and increasingly competitive business environment, every company must strive to make the best use of its constrained resources by furthering those assets which, despite their inherent risks and uncertainties, are likely to provide sustainable growth. Irrespective of whether a formal group oversees the portfolio management process, executives expect that the best data and information will be presented to them in order for logically consistent and defensible decisions to be made. Explore the different capabilities required to build portfolio management excellence, examine how budgets and human resources can best be utilized, and track the enhanced value of better decisionmaking processes. Finally, create an organizational culture in which every stakeholder sees himself/herself as a contributor to successful enterprise portfolio management.

The Masterclass begins with well-founded theory and quickly moves to practical implementation and executive decision-making based on the trainer’s expertise and experience with 3 major Pharmaceutical and Biotechnology companies (1996-2007) as well as consulting across several industry verticals (2008-present).

Dr. Bayney’s emphasis is on helping organizations move from portfolio value creation to portfolio value maximization by putting in place sequential building blocks to attain protracted excellence in portfolio management.

Further information
Scientific News
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.
Biologists Find Unexpected Role for Amyloid-Forming Protein
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
Revolutionary Gene-editing Technique to Stop AIDS Virus in Its Tracks
UNLV personalized medicine researchers seeking patent on potential HIV cure. Their technique uses a plant protein widely used in agriculture industry.
Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Tracking Changes in DNA Methylation In Real Time At Single-Cell Resolution
Whitehead Institute researchers have developed a methodology to monitor changes in DNA methylation over time in individual cells.
Virus Re-Engineered to Deliver Targeted Therapies
Researchers stripped a virus of its infectious machinery and turned its benign core into a delivery vehicle that can target sick cells while leaving healthy tissue alone.
Exposure to Pesticides In Childhood Linked to Cancer
Young children who are exposed to insecticides inside their homes may be slightly more at risk for developing leukemia or lymphoma during childhood, according to a meta-analysis by Harvard T.H. Chan School of Public Health researchers.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos